Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn’t fully recovered just yet
Angelp | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed signs of life during the first three months of 2024. But it’s …